FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 151 through 200 of 296

- SIC # 2830

Ticker Exchange Company Financial Reports SIC #
KYKOY Over the counter Kyowa Kirin Co., Ltd. 2830
KYMR Nasdaq Kymera Therapeutics, Inc. 2830
KYTX Nasdaq Kyverna Therapeutics, Inc. 2830
LEGN Nasdaq Legend Biotech Corporation 2830
LEXX Nasdaq Lexaria Bioscience Corp. 2830
LFCR Nasdaq Lifecore Biomedical, Inc. 2830
LIPO Nasdaq Lipella Pharmaceuticals Inc. 2830
LRMR Nasdaq Larimar Therapeutics, Inc. 2830
LSTA Nasdaq Lisata Therapeutics, Inc. 2830
LVTX Nasdaq LAVA Therapeutics N.V. 2830
LXRX Nasdaq Lexicon Pharmaceuticals, Inc. 2830
LYRA Nasdaq Lyra Therapeutics, Inc. 2830
MBX Nasdaq MBX Biosciences, Inc. 2830
MIST Nasdaq Milestone Pharmaceuticals Inc. 2830
MLYS Nasdaq Mineralys Therapeutics, Inc. 2830
MNKD Nasdaq MannKind Corporation 2830
MNMD Nasdaq Mind Medicine (MindMed) Inc. 2830
MOLN Nasdaq Molecular Partners AG 2830
MRK New York Merck & Co., Inc. 2830
MRKR Nasdaq Marker Therapeutics, Inc. 2830
MRNA Nasdaq Moderna, Inc. 2830
MRNS Nasdaq Marinus Pharmaceuticals, Inc. 2830
MRUS Nasdaq Merus N.V. 2830
MTNB NYSE American Matinas BioPharma Holdings, Inc. 2830
MURA Nasdaq Mural Oncology plc 2830
NAMS Nasdaq NewAmsterdam Pharma Company N.V. 2830
NEOG Nasdaq Neogen Corporation 2830
NGNE Nasdaq Neurogene Inc. 2830
NKTR Nasdaq Nektar Therapeutics 2830
NLSP Nasdaq NLS Pharmaceutics AG 2830
NNVC NYSE American NanoViricides, Inc. 2830
NRIX Nasdaq Nurix Therapeutics, Inc. 2830
NRSN Nasdaq NeuroSense Therapeutics Ltd. 2830
NRXP Nasdaq NRx Pharmaceuticals, Inc. 2830
NUVL Nasdaq Nuvalent, Inc. 2830
NVCT Nasdaq Nuvectis Pharma, Inc. 2830
NVO New York Novo Nordisk A/S 2830
NVS New York Novartis AG 2830
NXTC Nasdaq NextCure, Inc. 2830
OCS Nasdaq Oculis Holding AG 2830
OGEN NYSE American Oragenics, Inc. 2830
OKUR Nasdaq OnKure Therapeutics, Inc. 2830
OLMA Nasdaq Olema Pharmaceuticals, Inc. 2830
ONCO Nasdaq Onconetix, Inc. 2830
OPHLY Over the counter Ono Pharmaceutical Co., Ltd. 2830
ORINY Over the counter Orion Oyj 2830
ORMP Nasdaq Oramed Pharmaceuticals Inc. 2830
PALI Nasdaq Palisade Bio, Inc. 2830
PASG Nasdaq Passage Bio, Inc. 2830
PBYI Nasdaq Puma Biotechnology, Inc. 2830
Results 150 through 200 of 296